References
- McLntyre A. R. Curare. Endeavour 1949; 8: 32
- Ehrly A. M. Arwin - A New Therapeutic Agent, Med. Welt 1978; 29: 1144
- Nissen M. B. Streptokinase Therapy in Acute Myocardial Infarction. Heart & Lung 1984; 13: 223
- Roberts R., Pratt CM. Value of Intravenous Streptokinase in Acute Myocardial Infarction, Int. J. Cardiology 1984; 5: 637
- Yap H.-Y., Murphy W. K., DiStefano A., Blumenschein G. R., Bodey G. P. Phase II Study of Anquidine in Advanced Breast Cancer. Cancer Treat. Rep. 1979; 63: 789
- Thigpen J. T., Vaughn C., Stuckey W. J. Phase II Trial of Anquidine with Sarcomas Unresponsive to Prior Chemotherapy. Cancer Treat. Rep. 1981; 65: 881
- Goodwin J. W., Bottomley R. H., Vaughn C. B., Frank J., Pugh R. P. Phase II Evaluation of Anquidine in Central Nervous System Tumors. Cancer Treat. Rep. 1983; 67: 285
- Shoulson I., Goldblatt D., Charlton M., Joynt R. J. Huntington's Disease: Treatment with Muscimol, a GABA-mimetic Drug. Ann. Neurol. 1978; 4: 279
- Fodstad O., Kvalheim G., Godal A., Lotsberg J., Aamdal S., Hst H., Pihl A. Phase I Study of the Plant Protein Ricin. Cancer Res. 1984; 44: 862
- Buzzi S. Diphtheria Toxin Treatment of Human Advanced Cancer. Cancer Res. 1982; 42: 2054
- Nauts H. C. Bacterial Pyrogens: Beneficial Effects on Cancer Patients. Prog. Clin. Biol. Res. 1982; 107: 687
- Scott A. B. Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery. Ophthalmology 1980; 87: 1044
- Collier R. J., Kaplan D. A. Immunotoxins. Sci. Amer. 1984; 251(1)56
- Quinones R. R., Youle R. J., Kersey J. H., Zanjani E. D., Azemove S. M., Soderling C. C., Lebein P. W., Beverley P. C., Neville D. M., Vallera D. A. Anti-T Cell Monoclonal Antibodies Conjugated to Ricin as Potential Reagents for Human GVHD Prophylaxis. J. Immunol. 1984; 132: 678
- Myers CD., Thorpe P. E., Ross W.C, Cumber A. J., Katz F. E., Tax W., Greaves M. F. An Immunotoxin with Therapeutic Potential for T Cell Leukemia. Blood 1984; 63: 1178